Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
Identifieur interne : 007B19 ( Main/Exploration ); précédent : 007B18; suivant : 007B20Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
Auteurs : M. Liedtke [États-Unis] ; P. A. Hamlin [États-Unis] ; C. H. Moskowitz [États-Unis] ; A. D. Zelenetz [États-Unis]Source :
- Annals of Oncology [ 0923-7534 ] ; 2006-06.
English descriptors
- KwdEn :
Abstract
Background: Approximately one-third of the patients with relapsed aggressive non-Hodgkin's lymphoma (NHL) are cured by second-line chemotherapy followed by high-dose consolidation. The age-adjusted international prognostic index determined at the time of relapse (sAAIPI) predicts outcome in relapsed diffuse large B-cell lymphoma, suggesting that the success of salvage therapy could be enhanced by early relapse detection. This study evaluated the role of surveillance imaging in detection of relapsed disease and its impact on outcome of salvage treatment. Patients and methods: One hundred and eight patients with relapsed aggressive NHL were treated with ICE-based second-line chemotherapy. Relapses were categorized as detected by imaging, examination, or patient-reported symptoms. Results: Twenty per cent of relapses were detected by routine imaging while 80% were identified by reported symptoms or abnormalities on exam. Patients were 4.1 times (95% CI: 1.7–10.2) more likely to have low risk disease if relapse was diagnosed by routine imaging (group 1) compared with those diagnosed by reported symptoms or physical findings (group 2). Median overall 5-year survival for group 1 versus group 2 was 54% and 43% respectively (P = 0.13). Conclusion: These results suggest that routine surveillance imaging can identify a population of patients with a more favorable outcome based on the sAAIPI.
Url:
DOI: 10.1093/annonc/mdl049
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003752
- to stream Istex, to step Curation: 003752
- to stream Istex, to step Checkpoint: 001603
- to stream Main, to step Merge: 007D12
- to stream Main, to step Curation: 007B19
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population</title><author><name sortKey="Liedtke, M" sort="Liedtke, M" uniqKey="Liedtke M" first="M." last="Liedtke">M. Liedtke</name></author><author><name sortKey="Hamlin, P A" sort="Hamlin, P A" uniqKey="Hamlin P" first="P. A." last="Hamlin">P. A. Hamlin</name></author><author><name sortKey="Moskowitz, C H" sort="Moskowitz, C H" uniqKey="Moskowitz C" first="C. H." last="Moskowitz">C. H. Moskowitz</name></author><author><name sortKey="Zelenetz, A D" sort="Zelenetz, A D" uniqKey="Zelenetz A" first="A. D." last="Zelenetz">A. D. Zelenetz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7636295ABCA30EAABC1BF06E65B9ABED7BB2B778</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1093/annonc/mdl049</idno><idno type="url">https://api.istex.fr/document/7636295ABCA30EAABC1BF06E65B9ABED7BB2B778/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003752</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003752</idno><idno type="wicri:Area/Istex/Curation">003752</idno><idno type="wicri:Area/Istex/Checkpoint">001603</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001603</idno><idno type="wicri:doubleKey">0923-7534:2006:Liedtke M:surveillance:imaging:during</idno><idno type="wicri:Area/Main/Merge">007D12</idno><idno type="wicri:Area/Main/Curation">007B19</idno><idno type="wicri:Area/Main/Exploration">007B19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population</title><author><name sortKey="Liedtke, M" sort="Liedtke, M" uniqKey="Liedtke M" first="M." last="Liedtke">M. Liedtke</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Hamlin, P A" sort="Hamlin, P A" uniqKey="Hamlin P" first="P. A." last="Hamlin">P. A. Hamlin</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Moskowitz, C H" sort="Moskowitz, C H" uniqKey="Moskowitz C" first="C. H." last="Moskowitz">C. H. Moskowitz</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Zelenetz, A D" sort="Zelenetz, A D" uniqKey="Zelenetz A" first="A. D." last="Zelenetz">A. D. Zelenetz</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Oncology</title><title level="j" type="abbrev">Ann Oncol</title><idno type="ISSN">0923-7534</idno><idno type="eISSN">1569-8041</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2006-06">2006-06</date><biblScope unit="volume">17</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="909">909</biblScope><biblScope unit="page" to="913">913</biblScope></imprint><idno type="ISSN">0923-7534</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0923-7534</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>follow-up</term><term>lymphoma</term><term>relapse</term><term>surveillance imaging</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Approximately one-third of the patients with relapsed aggressive non-Hodgkin's lymphoma (NHL) are cured by second-line chemotherapy followed by high-dose consolidation. The age-adjusted international prognostic index determined at the time of relapse (sAAIPI) predicts outcome in relapsed diffuse large B-cell lymphoma, suggesting that the success of salvage therapy could be enhanced by early relapse detection. This study evaluated the role of surveillance imaging in detection of relapsed disease and its impact on outcome of salvage treatment. Patients and methods: One hundred and eight patients with relapsed aggressive NHL were treated with ICE-based second-line chemotherapy. Relapses were categorized as detected by imaging, examination, or patient-reported symptoms. Results: Twenty per cent of relapses were detected by routine imaging while 80% were identified by reported symptoms or abnormalities on exam. Patients were 4.1 times (95% CI: 1.7–10.2) more likely to have low risk disease if relapse was diagnosed by routine imaging (group 1) compared with those diagnosed by reported symptoms or physical findings (group 2). Median overall 5-year survival for group 1 versus group 2 was 54% and 43% respectively (P = 0.13). Conclusion: These results suggest that routine surveillance imaging can identify a population of patients with a more favorable outcome based on the sAAIPI.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Liedtke, M" sort="Liedtke, M" uniqKey="Liedtke M" first="M." last="Liedtke">M. Liedtke</name></region><name sortKey="Hamlin, P A" sort="Hamlin, P A" uniqKey="Hamlin P" first="P. A." last="Hamlin">P. A. Hamlin</name><name sortKey="Liedtke, M" sort="Liedtke, M" uniqKey="Liedtke M" first="M." last="Liedtke">M. Liedtke</name><name sortKey="Moskowitz, C H" sort="Moskowitz, C H" uniqKey="Moskowitz C" first="C. H." last="Moskowitz">C. H. Moskowitz</name><name sortKey="Zelenetz, A D" sort="Zelenetz, A D" uniqKey="Zelenetz A" first="A. D." last="Zelenetz">A. D. Zelenetz</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007B19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007B19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:7636295ABCA30EAABC1BF06E65B9ABED7BB2B778
|texte= Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
}}
| This area was generated with Dilib version V0.6.31. |  |